European Journal of Ophthalmology最新文献

筛选
英文 中文
Phakic intraocular Lens implantation in keratoconus patients. 角膜炎患者的角膜内人工晶体植入术。
IF 1.4 4区 医学
European Journal of Ophthalmology Pub Date : 2024-09-01 Epub Date: 2023-09-03 DOI: 10.1177/11206721231199780
Ali Nowrouzi, Francesco D'Oria, Jorge L Alió Del Barrio, Jorge L Alió
{"title":"Phakic intraocular Lens implantation in keratoconus patients.","authors":"Ali Nowrouzi, Francesco D'Oria, Jorge L Alió Del Barrio, Jorge L Alió","doi":"10.1177/11206721231199780","DOIUrl":"10.1177/11206721231199780","url":null,"abstract":"<p><strong>Background: </strong>Both the anterior chamber and posterior chamber phakic intraocular lenses (pIOLs) implantation are acceptable refractive surgical approaches in keratoconus patients with high anisometropia, contact lens intolerance, or who prefer spectacle and contact lens independent. They are beneficial for correcting anisometropia in stable keratoconus cases or following corneal procedures such as intrastromal corneal ring segments (ICRS), collagen cross-linking (CXL), and keratoplasty. They are suitable for eyes without advanced keratoconus with acceptable best-corrected distance visual acuity (BCDVA) or without highly irregular astigmatism, high comma, and higher-order aberrations (HOAs). Combined procedures for irregular astigmatism reduction and corneal regularization with either ICRS or topography/wavefront-guided transepithelial PRK (with or without CXL) can be associated in advance with pIOLs implantation to improve BCDVA in these cases.</p><p><strong>Aim: </strong>To study and report the evidence regarding the safety and efficacy of pIOLs for KC patients' visual and refractive rehabilitation, we have analyzed the scientific evidence published within the last 10 years (from 2012 onwards).</p><p><strong>Results: </strong>No randomized controlled trials but only eleven retrospective case series and two prospective case series were identified. Satisfactory visual rehabilitation was achieved regarding uncorrected and corrected distance visual acuity (CDVA) and predictability of the refractive correction. Both types of pIOL (iris claw and posterior chamber pIOLs) offer very good results in terms of safety and efficacy with indexes close to or even exceeding 1.</p><p><strong>Conclusion: </strong>pIOLs implantation is a valid refractive therapeutic approach for correcting stable keratoconus with moderate-to-high refractive errors, especially anisometropia associated with regular or mildly irregular astigmatism, and good CDVA.</p>","PeriodicalId":12000,"journal":{"name":"European Journal of Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10149403","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relationship between visual acuity and OCT angiography parameters in diabetic retinopathy eyes after treatment. 糖尿病视网膜病变患者治疗后视力与 OCT 血管造影参数之间的关系。
IF 1.4 4区 医学
European Journal of Ophthalmology Pub Date : 2024-09-01 Epub Date: 2024-01-30 DOI: 10.1177/11206721241228010
Selena Wei-Zhang, Kai He, Wei Zhou, Jinguo Yu, Jing Zhao, Tiangeng He, Song Chen, Parhat Kaysar, Zhiyong Sun, Dagong Jia, Yun Zhu, Hua Yan
{"title":"Relationship between visual acuity and OCT angiography parameters in diabetic retinopathy eyes after treatment.","authors":"Selena Wei-Zhang, Kai He, Wei Zhou, Jinguo Yu, Jing Zhao, Tiangeng He, Song Chen, Parhat Kaysar, Zhiyong Sun, Dagong Jia, Yun Zhu, Hua Yan","doi":"10.1177/11206721241228010","DOIUrl":"10.1177/11206721241228010","url":null,"abstract":"<p><strong>Purpose: </strong>To assess the relationship between visual acuity and OCT angiography parameters in diabetic retinopathy eyes after treatment, and to analyze the relative factors in PDR eyes.</p><p><strong>Methods: </strong>A total of 89 eyes, including 42 eyes with non-PDR (NPDR), and 47 eyes after vitrectomy with PDR were included and underwent OCTA. All images were processed by Python or FIJI. Multivariable linear regression models were used to analyze the associations between postoperative BCVA and OCTA parameters in PDR patients.</p><p><strong>Results: </strong>Postoperative OCTA parameters including deep capillary plexus (DCP) parafoveal and perifoveal vessel density (VD), DCP parafoveal and perifoveal vessel length density (VLD), DCP fractal dimension (FD), choriocapillaris plexus (CCP) VD, CCP VLD, were significantly lower in the PDR group than in the NPDR group. In the superficial capillary plexus (SCP), we found a negative correlation between the postoperative BCVA and VD (parafovea: β coefficient = -0.351, <i>p</i> = 0.023; perifovea: β coefficient = -0.338, <i>p</i> = 0.036). Perifoveal VLD (β coefficient = -0.343, <i>p</i> = 0.031) and FD (β coefficient = -0.375, <i>p</i> = 0.016) of the SCP were also negatively correlated with postoperative BCVA. Regarding the DCP, perifoveal VD (β coefficient = -0.396, <i>p</i> = 0.008), perifoveal VLD (β coefficient = -0.334, <i>p</i> = 0.025), vessel tortuosity (VT) (β coefficient = -0.369, <i>p</i> = 0.015) were negatively correlated with postoperative BCVA. In CCP, VLD (β coefficient = -0.373, <i>p</i> = 0.023) and number of flow voids (β coefficient = -0.334, <i>p</i> = 0.036) exhibited a negative association with postoperative BCVA.</p><p><strong>Conclusions: </strong>Postoperative BCVA of PDR patients was related to OCTA parameters of the SCP (parafoveal and perifoveal VD, perifoveal VLD and FD), DCP (perifoveal VD, VLD, and VT) and CCP (VLD and number of flow voids).</p>","PeriodicalId":12000,"journal":{"name":"European Journal of Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139641937","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ocular Lichen Planus: A clinicopathologic review. 眼扁平苔藓:临床病理学回顾
IF 1.4 4区 医学
European Journal of Ophthalmology Pub Date : 2024-09-01 Epub Date: 2024-02-02 DOI: 10.1177/11206721241229128
Ian R Reekie, Alasdair Simpson, Ore Erikitola, Douglas Lyall, Fiona Roberts
{"title":"Ocular Lichen Planus: A clinicopathologic review.","authors":"Ian R Reekie, Alasdair Simpson, Ore Erikitola, Douglas Lyall, Fiona Roberts","doi":"10.1177/11206721241229128","DOIUrl":"10.1177/11206721241229128","url":null,"abstract":"<p><p>Lichen planus is a chronic inflammatory dermatosis that can affect the skin, mucous membranes and nails. Cutaneous lichen planus lesions are best described by the \"six Ps\" - purple pruritic polygonal planar papules and plaques. Mucous membrane lesions are commonly associated with cutaneous lichen planus<b>.</b> Ocular involvement with lichen planus is rare and conjunctival involvement usually predominates, it can however be visually devastating. Ocular lichen planus often progresses to extensive conjunctival scarring which can be impossible to distinguish clinically from other cicatrising conjunctivitis, requiring histopathological confirmation. Here we review the ocular pathology of this condition.</p>","PeriodicalId":12000,"journal":{"name":"European Journal of Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139671563","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Non-steroidal intravitreal injection for noninfectious uveitic cystoid macular edema: Systematic review and meta-analysis. 非甾体玻璃体内注射治疗非感染性葡萄膜炎囊样黄斑水肿:系统综述和荟萃分析。
IF 1.4 4区 医学
European Journal of Ophthalmology Pub Date : 2024-09-01 Epub Date: 2023-11-06 DOI: 10.1177/11206721231212777
Farzan Kianersi, Abdolreza Rezaeian-Ramsheh, Alireza Rahimi, Mohammadreza Akhlaghi, Alireza Dehghani, Ziba Farajzadegan, Mohsen Pourazizi
{"title":"Non-steroidal intravitreal injection for noninfectious uveitic cystoid macular edema: Systematic review and meta-analysis.","authors":"Farzan Kianersi, Abdolreza Rezaeian-Ramsheh, Alireza Rahimi, Mohammadreza Akhlaghi, Alireza Dehghani, Ziba Farajzadegan, Mohsen Pourazizi","doi":"10.1177/11206721231212777","DOIUrl":"10.1177/11206721231212777","url":null,"abstract":"<p><strong>Purpose: </strong>To systematically review the published manuscripts on the non-steroidal intravitreal injection for treatment of noninfectious uveitic cystoid macular edema (CME).</p><p><strong>Methods: </strong>The PubMed, Scopus, and Web of Science, Science Direct, ProQuest, Cochrane Library, ProQuest, Embase, Clinical Key, and Springer were searched for relevant articles published until May 2022. The random-effects models were used to estimate the mean difference (MD) and 95% confidence interval (CI) for postoperative central macular thickness (CMT) and visual acuity (VA) changes. VA was transformed into the logarithm of the minimum angle of resolution (LogMAR). Meta-regression was conducted for adjusting the effects of potential confounders.</p><p><strong>Results: </strong>A total of 17 relevant studies (258 eyes) were included in this meta-analysis. A significant improvement was observed in CMT in the last follow up (350.89 ± 108.43) compared to the baseline (452.3 ± 112.67) (Log MD = 1.82, 95% CI = 1.62, 2.02; I2 = 57.7%; P = 0.002). Additionally, VA also significantly improved in the last follow up (0.56 ± 0.29) compared to the baseline (0.75 ± 0.3) (Exponential MD = 0.82, 95% CI = 0.69, 0.95; I<sup>2</sup> = 0.0%; P = 0.98). The subgroups analyzed included ten studies on anti-vascular endothelial growth factors (VEGF), three studies on infliximab, two studies on methotrexate (MTX), and two studies on diclofenac. All subgroups showed a significant improvement in both CMT and VA at the last follow-up (P < 0.05).</p><p><strong>Conclusion: </strong>Non-steroidal intravitreal injection including bevacizumab, ranibizumab, infliximab, MTX and diclofenac appears to be an effective treatment option for noninfectious uveitic CME.</p>","PeriodicalId":12000,"journal":{"name":"European Journal of Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71479712","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Radiation-induced ophthalmic risks of long duration spaceflight: Current investigations and interventions. 长期太空飞行的辐射诱发眼科风险:目前的调查和干预措施。
IF 1.4 4区 医学
European Journal of Ophthalmology Pub Date : 2024-09-01 Epub Date: 2023-12-27 DOI: 10.1177/11206721231221584
Ethan Waisberg, Joshua Ong, Phani Paladugu, Sharif Amit Kamran, Nasif Zaman, Alireza Tavakkoli, Andrew G Lee
{"title":"Radiation-induced ophthalmic risks of long duration spaceflight: Current investigations and interventions.","authors":"Ethan Waisberg, Joshua Ong, Phani Paladugu, Sharif Amit Kamran, Nasif Zaman, Alireza Tavakkoli, Andrew G Lee","doi":"10.1177/11206721231221584","DOIUrl":"10.1177/11206721231221584","url":null,"abstract":"<p><strong>Purpose: </strong>As the average duration of space missions increases, astronauts will experience longer periods of exposure to risks of long duration space flight including microgravity and radiation. The risks from long-term exposure to space radiation remains ill-defined. We review the current literature on the possible and known risks of radiation on the eye (including radiation retinopathy) after long duration spaceflight.</p><p><strong>Methods: </strong>A PubMed and Google Scholar search of the English language ophthalmic literature was performed from inception to July 11, 2022. The following search terms were utilized independently or in conjunction to build this manuscript: \"Radiation Retinopathy\", \"Spaceflight\", \"Space Radiation\", \"Spaceflight Associated Neuro-Ocular Syndrome\", \"Microgravity\", \"Hypercapnia\", \"Radiation Shield\", \"Cataract\", and \"SANS\". A concise and selective approach of references was conducted in including relevant original studies and reviews.</p><p><strong>Results: </strong>A total of 65 papers were reviewed and 47 papers were included in our review.</p><p><strong>Conclusion: </strong>We discuss the potential and developing countermeasures to mitigate these radiation risks in preparation for future space exploration. Given the complex nature of space radiation, no single approach will fully reduce the risks of developing radiation maculopathy in long-duration spaceflight. Understanding and appropriately overcoming the risks of space radiation is key to becoming a multi-planetary species.</p>","PeriodicalId":12000,"journal":{"name":"European Journal of Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139048579","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Increased expression of neutrophil CD15 correlates with the severity of anterior ocular surface damage in type II diabetes mellitus. 中性粒细胞 CD15 表达的增加与 II 型糖尿病患者眼球前表面损伤的严重程度相关。
IF 1.4 4区 医学
European Journal of Ophthalmology Pub Date : 2024-09-01 Epub Date: 2023-12-28 DOI: 10.1177/11206721231222947
Tetiana Zhmud, Stefano Barabino, Nataliia Malachkova
{"title":"Increased expression of neutrophil CD15 correlates with the severity of anterior ocular surface damage in type II diabetes mellitus.","authors":"Tetiana Zhmud, Stefano Barabino, Nataliia Malachkova","doi":"10.1177/11206721231222947","DOIUrl":"10.1177/11206721231222947","url":null,"abstract":"<p><strong>Background: </strong>Diabetes mellitus is associated with increased risk of ocular surface diseases in elderly. We consider neutrophil CD15 as a potential marker of ocular surface damage in type II diabetes mellitus patients.</p><p><strong>Aim: </strong>We aimed to evaluate expression of neutrophil CD15 and correlate it with results of conjunctival impression cytology and routine objective anterior ocular surface tests (TMH, NIBUT, LLT, MGD) in T2DM patients.</p><p><strong>Materials and methods: </strong>We prospectively enrolled sixty type II diabetes mellitus patients (120 eyes) into a study group. The control group included forty (80 eyes) age- and sex-matched healthy individuals. All patients underwent comprehensive ophthalmological examination, and tear meniscus height test (TMH), noninvasive tear break-up time (NIBUT), lipid layer thickness measurement (LLT), Meibomian gland dysfunction evaluation (MGD), conjunctival impression cytology (CIC) and expression of CD15.</p><p><strong>Results: </strong>Abnormal Nelson's grades of squamous metaplasia (grades 2 and 3) were observed in 50% (60 eyes) of the study group, and 13.8 (11 eyes) of the control group. Fifteen patients with type II diabetes mellitus suffered from grade 3 squamous metaplasia. Nelson's grades of squamous metaplasia have shown a positive correlation with the level of CD15 expression either in the study and control groups (rs = 0.628, <i>p </i>= <0.0001; rs = 0.746, <i>p</i> < 0.0001; respectively).</p><p><strong>Conclusions: </strong>The research shows significantly reduced values of routine objective ocular tests in type II diabetes mellitus patients in comparison to healthy participants older than 60 y.o. Increased CD15 in the peripheral blood is associated with the development of squamous metaplasia and may be used to evaluate the severity of ocular surface damage in type II diabetes mellitus patients.</p>","PeriodicalId":12000,"journal":{"name":"European Journal of Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139048571","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optical coherence tomography characteristics and factors affecting visual acuity in diabetic papillopathy. 糖尿病乳头状瘤病的光学相干断层扫描特征和影响视力的因素。
IF 1.4 4区 医学
European Journal of Ophthalmology Pub Date : 2024-09-01 Epub Date: 2024-01-09 DOI: 10.1177/11206721231225989
Udit Ajmani, Brijesh Takkar, Padmaja Kumari Rani, Jay Chhablani, Niroj Kumar Sahoo
{"title":"Optical coherence tomography characteristics and factors affecting visual acuity in diabetic papillopathy.","authors":"Udit Ajmani, Brijesh Takkar, Padmaja Kumari Rani, Jay Chhablani, Niroj Kumar Sahoo","doi":"10.1177/11206721231225989","DOIUrl":"10.1177/11206721231225989","url":null,"abstract":"<p><strong>Purpose: </strong>To analyse baseline imaging characteristics and factors affecting poor visual acuity in diabetic papillopathy.</p><p><strong>Methods: </strong>This was a retrospective, observational study conducted at a tertiary eye care centre in eyes with a diagnosis of diabetic papillopathy. Demographic data including age, gender, duration of diabetes, type of diabetes, HbA1c values and other systemic co-morbidities were recorded. Baseline best corrected visual acuity (BCVA), and various imaging characteristics were noted.</p><p><strong>Results: </strong>37 eyes of 22 patients with diagnosis of diabetic papillopathy were included [mean age of 46.6 ± 13.5 years, five (22.7%) females and 17 (77.3%) males]. Bilateral involvement was seen in 15 (68.2%) patients. The mean baseline BCVA was 0.51 ± 0.49 logMAR (Snellen equivalent 20/60). Two eyes (5.4%) had features of concurrent mild NPDR, 9 eyes (24.3%) had moderate NPDR, 10 eyes (27.03%) had severe NPDR while 16 (43.2%) other had PDR. All eyes had optic disc edema while 4 had disc pallor at presentation. Telangiectatic vessels/ neovascularisation of disc was present in 17 eyes (45.9%) detected either clinically or on optical coherence tomography (OCT) angiography. 11 (29.7%) eyes had a peripapillary cuff of subretinal fluid accompanying the disc edema. Sixteen eyes (43.2%) had centre involving macular edema seen on OCT. In eyes with a macular edema, the mean central macular thickness was 407.4 ± 71.42 microns at baseline. On assessing the baseline factors that contribute to the final visual acuity, presenting visual acuity was the only variable found to be statistically significant.</p><p><strong>Conclusion: </strong>Although described to have good visual outcome, eyes presenting with poor visual acuity tend to have worse vision on follow up. This may aid in prognosticating and guiding management plan.</p>","PeriodicalId":12000,"journal":{"name":"European Journal of Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139402484","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The long-term effects of topical latanoprost 0.005% treatment on pupillary functions: A 2-year longitudinal study. 0.005% 拉坦前列素局部治疗对瞳孔功能的长期影响:为期两年的纵向研究。
IF 1.4 4区 医学
European Journal of Ophthalmology Pub Date : 2024-09-01 Epub Date: 2024-01-18 DOI: 10.1177/11206721241227780
Serdar Bayraktar, Gözde Hondur, Mehmet Ali Şekeroğlu, Beyhan Cengiz Özyurt, Emine Şen
{"title":"The long-term effects of topical latanoprost 0.005% treatment on pupillary functions: A 2-year longitudinal study.","authors":"Serdar Bayraktar, Gözde Hondur, Mehmet Ali Şekeroğlu, Beyhan Cengiz Özyurt, Emine Şen","doi":"10.1177/11206721241227780","DOIUrl":"10.1177/11206721241227780","url":null,"abstract":"<p><strong>Purpose: </strong>To investigate the long-term effects of topical latanoprost 0.005% treatment on pupillary functions in early-stage primary open-angle glaucoma (POAG) eyes using automated pupillometry.</p><p><strong>Methods: </strong>This prospective study involved 20 eyes of 20 treatment-naive subjects with early-stage POAG. After comprehensive ophthalmic examination, static and dynamic pupillometry measurements were performedbefore treatment, at the 1st follow-up visit (1.10 ± 0.30 months) and the 2nd follow-up visit (25.85 ± 10.26 months) after treatment initiation. Dynamic parameters included resting diameter (mm), amplitude (mm), latency (ms), duration (ms), and velocity (mm/s) of pupil contraction and dilation. Static pupillometry parameters were pupil diameter (PD, mm) in high-photopic, low-photopic, mesopic and scotopic conditions.</p><p><strong>Results: </strong>The velocity of pupil dilation significantly decreased during the 1st visit (<i>p</i> = 0.008) and the 2nd visit (<i>p</i> = 0.0003) of treatment compared to the pre-treatment visit. The resting PD was also significantly higher after the 1st visit (<i>p</i> = 0.003) and the 2nd visit (<i>p</i> = 0.001) compared to the pre-treatment visit. However, the difference in resting PD measured between the 1st and 2nd visits did not reach statistical significance (<i>p</i> = 0.065). There were no significant changes in other dynamic parameters (<i>p</i> > 0.05 for all). Additionally, a mild, but not significant, mydriatic effect was observed in PD measurements under scotopic, mesopic and low photopic lighting conditions after follow-up. None of the static and dynamic parameters correlate with age, changes in intraocular pressure (IOP) or mean deviation (MD) values of visual field tests.</p><p><strong>Conclusion: </strong>The long-term topical latanoprost 0.005% treatment in early-stage POAG has a slight mydriatic effect on the pupil. Further longitudinal clinical studies with larger patient cohorts are necessary to better understand the effects of latanoprost on pupillary functions.</p>","PeriodicalId":12000,"journal":{"name":"European Journal of Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139489953","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unveiling novel LRP5 pathogenic variant in familial exudative vitreoretinopathy: Diverse phenotypic expressions in a mother-daughter duo. 揭示家族性渗出性玻璃体视网膜病变的新型 LRP5 致病变体:一对母女的不同表型表现
IF 1.4 4区 医学
European Journal of Ophthalmology Pub Date : 2024-09-01 Epub Date: 2024-05-08 DOI: 10.1177/11206721241254129
Hsin-Ho Chang, An-Guor Wang, Dau-Ming Niu, Yun-Ru Chen, Chang-Chi Weng
{"title":"Unveiling novel <i>LRP5</i> pathogenic variant in familial exudative vitreoretinopathy: Diverse phenotypic expressions in a mother-daughter duo.","authors":"Hsin-Ho Chang, An-Guor Wang, Dau-Ming Niu, Yun-Ru Chen, Chang-Chi Weng","doi":"10.1177/11206721241254129","DOIUrl":"10.1177/11206721241254129","url":null,"abstract":"<p><strong>Purpose: </strong>This report aims to delineate distinct phenotypes of Familial Exudative Vitreoretinopathy (FEVR) observed in a mother and her daughter, both harboring a novel <i>LRP5</i> pathogenic variation.</p><p><strong>Methods: </strong>The investigation involves a retrospective review of medical records accompanied by multimodal imaging. Molecular characterization was performed using whole exon sequencing, and the pathogenic variant was subsequently confirmed through Sanger sequencing.</p><p><strong>Result: </strong>A 6-year-old girl diagnosed with anisometropic amblyopia exhibited macular dragging and peripheral avascular retina in her right eye. Whole exon sequencing identified a previously unreported heterozygous missense <i>LRP5</i> pathogenic variation, Glu528Lys. Simultaneously, her 43-year-old mother also carried the same mutation, manifesting peripheral exudations, avascular areas, and multiple microaneurysms. Notably, both cases presented distinctive phenotypes of FEVR.</p><p><strong>Conclusion: </strong>Our findings underscore the diversity in clinical presentations associated with FEVR, emphasizing the pivotal role of genetic evaluation. Despite variations in severity between the eyes of the same patient, it is crucial to remain vigilant for potential progression to a pathological status in the seemingly normal eye. Additionally, this study contributes to expanding the genetic spectrum of FEVR.</p>","PeriodicalId":12000,"journal":{"name":"European Journal of Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140891503","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and safety evaluation of Monoblue Dual View and Monoblue ILM View vital stains during vitrectomy surgery. 玻璃体切除手术中 Monoblue Dual View 和 Monoblue ILM View 生命染色剂的有效性和安全性评估。
IF 1.4 4区 医学
European Journal of Ophthalmology Pub Date : 2024-09-01 Epub Date: 2024-06-13 DOI: 10.1177/11206721241261099
Gauthier Blanckaert, Joris Vander Mijnsbrugge, Ann-Laure Delbecq, Jean-François Fils, Joyce Jansen, Joachim Van Calster, Peter Stalmans
{"title":"Efficacy and safety evaluation of Monoblue Dual View and Monoblue ILM View vital stains during vitrectomy surgery.","authors":"Gauthier Blanckaert, Joris Vander Mijnsbrugge, Ann-Laure Delbecq, Jean-François Fils, Joyce Jansen, Joachim Van Calster, Peter Stalmans","doi":"10.1177/11206721241261099","DOIUrl":"10.1177/11206721241261099","url":null,"abstract":"<p><strong>Purpose: </strong>To compare the staining properties of Monoblue inner limiting membrane (ILM) View and Monoblue DUAL View (study products) vital stains during vitrectomy surgery to those of ILM Blue or Membrane Blue Dual (control products).</p><p><strong>Methods: </strong>In this study, 105 patients were included in the Ophthalmic Clinic of the University Hospitals Leuven from September 2021 to April 2022. For prospective data collection in this study, patients were randomized between a control group (ILM Blue or Membrane Blue Dual, manufactured and commercialized by DORC®) and a study group (Monoblue ILM View or Monoblue DUAL View, manufactured and commercialized by Arcadophta®-BVI®). For retrospective data collection, patients were divided into similar surgery groups. Efficacy was analyzed using a binary subjective evaluation of the visualization of stained membranes during vitrectomy. The rate and severity of potential adverse events related to the study products were tracked, allowing both treatment groups to be compared with the corresponding control groups (ILM Blue and Membrane Blue Dual).</p><p><strong>Results: </strong>Based on the results and findings, none of the comparisons (primary outcomes) were statistically significant, showing similar efficacy of the dyes used. The study products were found to be safe in this study since no serious adverse events were reported.</p><p><strong>Conclusions: </strong>The present findings indicate that the Monoblue ILM View and Monoblue DUAL View dyes can safely be used during vitrectomy to stain the ILM and/or epiretinal membrane (ERM) when removal is needed.</p>","PeriodicalId":12000,"journal":{"name":"European Journal of Ophthalmology","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141317146","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信